Thursday, 02 May 2024
Odonate Therapeutics Inc.
13:11 | 28/2/18
GuruFocus.com
CEO of Odonate Therapeutics Inc (NASDAQ:ODT) Kevin C Tang bought 28,612 shares of ODT on 02/27/2018 at an average price of $27.42 a share.
more»
14:07 | 23/2/18
GuruFocus.com
CEO of Odonate Therapeutics Inc (NASDAQ:ODT) Kevin C Tang bought 39,083 shares of ODT on 02/22/2018 at an average price of $27.17 a share.
more»
02:07 | 15/2/18
Business Wire
SAN DIEGO--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced financial results for ...
more»
08:19 | 4/1/18
Frisco Fastball
Among 3 analysts covering Odonate Therapeutics (ODT), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Odonate Therapeutics has $40 highest and $27 lowest target.
more»
But Odonate's stock isn't necessarily a buy, and investors may find better value elsewhere, the analyst said. Specifically, Goldman's $27 price target is based on a discounted cash flow model that assumes a 13-percent weighted average cost of capital ...
more»
02:52 | 29/12/17
Business Wire
SAN DIEGO--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced that it has initiated ...
more»
05:07 | 28/12/17
Clawson News
Shares of Odonate Therapeutics Inc. (ODT) have seen the needle move 2.04% or 0.50 in the most recent session. The NASDAQ listed company saw a recent bid of 24.95 on 58807 volume.
more»
08:52 | 20/12/17
Insider Monkey (blog)
Odonate Therapeutics Inc (NASDAQ:ODT): Kevin C. Tang's Tang Capital Partners LP filed an amended 13D. You can check out Tang Capital Management's latest holdings and filings here.
more»
05:52 | 19/12/17
The Ledger Gazette
Odonate Therapeutics earned a coverage optimism score of -0.01 on Accern's scale. Accern also gave headlines about the company an impact score of 46.3371896308774 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect ...
more»
04:00 | 19/12/17
Seeking Alpha
Odonate Therapeutics (ODT) is an oncology company focusing on breast cancer with an orally administered taxane class compound.
more»
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |